RE:RE:RE:RE:RE:Big Pharma is facing a looming $236 Billion patent cliffJune 20, 2022 - Interview with Andrew Callaway - Global Head, Healthcare Investment Banking, RBC Capital Markets Vito Sperduto: There is a large wave of healthcare patents that are coming due in two to five years’ time. As you talk to clients in that wave, what are they looking to do to replace the revenue they will lose?
Andrew Callaway: Clients will respond by entering the M&A market. We will see significant activity as people look to bolster not only pipelines but commercial portfolios.
Vito Sperduto: Can you summarize how you are thinking about 2022?
Andrew Callaway: With relatively quiet capital markets, we are spending significant time with management teams and boards looking at strategic transactions. So I think we will see a big wave of M&A as we move to the second half of 2022.
https://endpts.com/sp/ma-a-critical-driver-for-sustainable-top-line-growth-in-healthcare/